David Li, MD, University of British Columbia, Vancouver, Canada, explains the importance of a standardized MRI protocol for diagnosing and treating multiple sclerosis (MS). The use of different scanners can lead to differences in images that can be misinterpreted as new lesions. Adopting a standardized protocol means that physicians can confidently identify lesions, allowing for MS diagnosis, and can identify new lesions that patients have developed whilst on treatment, allowing physicians to make appropriate decisions about changing treatments. This interview took place at the Consortium of Multiple Sclerosis Centers (CMSC) Congress 2023 in Aurora, CO.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
David Li is Emeritus Director of the UBC MS/MRI Research Group which has received grant support for investigator-initiated studies from Genzyme, Novartis and Roche. He has served on the PML-MS Steering Committee for Biogen He has given lectures, supported by non-restricted education grants from Academy of Health Care Learning, Biogen, Consortium of MS Centers and Sanofi-Genzyme.